Appointment booking for Dr. Jeffrey Lisse, MD is currently not available.Dr. Jeffrey Lisse, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Jeffrey Lisse, MD (he/him) is a Rheumatologist in Tucson, AZ with over 18 years of experience. What is your opinion of Dr. Jeffrey Lisse, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jeffrey Lisse, MD has received over $62,791 which includes payments from the following companies:
$23,506.83 from LILLY USA, LLC
$9,852.23 from UCB, Inc.
$5,507.13 from Amgen Inc.
$4,462.82 from Janssen Biotech, Inc.
$4,449.20 from Baxter Healthcare
$3,985.43 from Regeneron Pharmaceuticals, Inc.
$3,861.85 from Pfizer Inc.
$2,622.37 from Genentech USA, Inc.
$2,377.93 from ELI LILLY AND COMPANY
$1,750.56 from UCB GmBH
$250.00 from Novartis Pharmaceuticals Corporation
$130.00 from GlaxoSmithKline, LLC.
$35.00 from Alexion Pharmaceuticals, Inc.
Payments received by Dr. Jeffrey Lisse, MD were from the following categories:
$41,405.00 Consulting Fee
$15,174.30 Travel and Lodging
$4,680.01 Food and Beverage
$1,000.00 Honoraria
$529.18 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!